Adhesives maker's fiscal Q3 revenue rose 5% yr/yr but missed analyst expectations
Adjusted EPS for fiscal Q3 rose 21% yr/yr, beating analyst expectations
Company says margin gains were driven by pricing execution and restructuring savings
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$938.17 mln
$948.19 mln (7 Analysts)
Q3 Adjusted EPS
Beat
$1.52
$1.47 (7 Analysts)
Q3 Adjusted Net Income Attributable
Beat
$83.42 mln
$81.27 mln (6 Analysts)
Analyst coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for H.B. Fuller Company is $75.00, about 46.9% above its September 22 closing price of $51.07
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 13 three months ago
Fiscal 2026 outlook
H.B. Fuller expects fiscal 2026 adjusted EBITDA of $655 mln to $670 mln
Company sees fiscal 2026 adjusted EPS (diluted) between $4.70 and $4.85
H.B. Fuller expects fiscal 2026 cash flow from operations of $300 mln to $325 mln, excluding AMS items
Drivers of the quarter
Pricing actions — company said pricing increased net revenue by 7.4%, offsetting lower volume and driving organic growth
Restructuring savings — company said restructuring efforts contributed to margin improvement and profitability
Strategic inventory investments — company said higher net working capital was driven by inventory investments to support Quantum Leap and supply continuity amid Middle East disruption
FUL•
